Dissertation > Excellent graduate degree dissertation topics show

Risperidone single osmotic pump tablets of

Author: WuXiaoWei
Tutor: SuZuo；MeiXingGuo
School: Shenyang Pharmaceutical University
Course: Microbial and Biochemical Pharmacy
Keywords: risperidone 9-hydroxyrisperidone osmotic pump tablet relative bioavailability
CLC: R94
Type: Master's thesis
Year: 2008
Downloads: 314
Quote: 0
Read: Download Dissertation

Abstract


In this paper, water-insoluble risperidone with low dose was selected as a model drug to prepare mono-layer osmotic pump tablets （MOPT）. Then, pharmacokinetic study of risperidone mono-layer osmotic pump tablets was performed in six beagle dogs.For preparation of elementary osmotic pump tablets with the poorly water-soluble drug, citric acid was used to modulate the solubility of risperidone within the core. In this paper, Similarity factors （f2） was used as the evaluation standard. Based on single-factor experiments, the amount of citric acid in the tablet core, the content of PEG 4000 in coating membrane and coating thickness were selected as the causal factors, the synthetical mark was used as the evaluation to optimize the formulations according to orthogonal experiment design. The results indicated that the optimal formulation had the excellent zero-order release character, good reproducibility of different batches, and its drug release was almost complete. The primary stability test showed that risperidone osmotic pump tablets were sensible to humidity, so the tablets should be stored hermetically.With the commercial common risperidone tablet as the reference, the pharmacokinetics study of self-prepared risperidone MOPT was performed in six Beagle dogs. With two-preparation and two-period crossover design, LC-MS-MS was employed to detect the plasma drug concentration of dogs administered with single dose. The pharmacokinetic parameters of the testing and reference tablets were as below: AUC0-∞ were 101.32±20.18 and 116.01±24.38 (ng·h·mL-1),ρmax werel2.87±3.15 and 73.51±11.86 (ng·mL-1), tmax were 3.70±0.52 and 0.71±0.10 （h）, relative bioavailability was 89.74±21.79% of risperidone; AUC0-∞ were 1409.92±141.39 and 1447.53±171.09 (ng·h·mL-1),ρmax were 86.37±6.26 and 200.42±29.68(ng·mL-1), tmax were 9.2±0.41和0.71±0.10（h）, relative bioavailability was 98.80±16.51% of 9-hydroxyrisperidone. AUC0-∞ were 1511.99±159.51 and 1560.03±189.05 (ng·h·mL-1),ρmax were 94.24±7.18 and 270.58±38.28 (ng·mL-1), tmax were 9.0±0.63 and 0.71±0.10 （ h ）, relative bioavailability was 98.31±16.33% of active moity（risperidone+ 9-hydroxyrisperidone）. The relation between in vitro drug release rate and in vivo drug release rate calculated, the results showed that the correlationship was excellent and the correlation factor was 0.9950.

Related Dissertations

  1. Effects of Antipsychotics Treatment on Blood-Lipid of Patients with Schizophrenia,R749.3
  2. Effects of Risperidone and Aripiparzole on Glucose, Lipid and Plasma Cytokine Levels in Schizophrenic Patients,R749.3
  3. Hydrochloric barnidipine from micro -emulsifying drug delivery system research,R94
  4. Isosorbide mononitrate sustained release pellets by,R94
  5. Vinpocetine situ and in situ gel microspheres and evaluation,R94
  6. Nitrendipine gastric floating sustained release microspheres,R94
  7. Pharmacokinetic Comparison of a Generic Flupentixol-Melitracen Tablets and the Innovator Preparation in Humans,R96
  8. Studies on the Orally Disintegrating Tablet of Nitrendipine,R94
  9. Studies on Famotidine Sustained-Release Floating Pellets,R944
  10. The Studies on the Floating Sustained-release Capsule of Bifendate,R94
  11. The Studies on Pharmacokinetics and Tissue Distribution of Pmea Prodrugs by Hplc with Fluorescence Detection,R96
  12. Preparation and Characterization of pH-sensitive Insulin Nanoparticles,TQ464
  13. Preparation of Alprazolam Orally Disintegrating Tablet,R94
  14. The Preparation Research of Solid SMEDDS for Oryzanol,R944
  15. The Studies on Pharmacokinetics and Tissue Distribution of PMEA Prodrugs,R96
  16. Acipimox Preparation and evaluation of osmotic pump,TQ460.6
  17. Preparation of Venlafaxine Hydrochloride Osmotic Pump Release Tablets,R94
  18. The Studies on the Sustained-Release Dropping Pills of Dipyridamole,R944.9
  19. Studies on the Insulin Liposome Dry Powder Inhalation,R944.9
  20. Study on Ketoprofen Monolithic Osmotic Pump Controlled-release Tablet,R94
  21. Study on Nimodipine Sustained-Release Pellets,R94

CLC: > Medicine, health > Pharmacy > Pharmacy
© 2012 www.DissertationTopic.Net  Mobile